Endothelin a receptor (ETa) antagonists in combination with phosphodiesterase 5 inhibitors (PDE5) and uses thereof

Details for Australian Patent Application No. 2005280077 (hide)

Owner Encysive Pharmaceuticals

Inventors Keyser, Donald Jeffrey; Dixon, Richard

Agent FB Rice

Pub. Number AU-A-2005280077

PCT Pub. Number WO2006/026395

Priority 60/604,462 26.08.04 US; 11/211,099 25.08.05 US

Filing date 26 August 2005

Wipo publication date 9 March 2006

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/026395 Priority application(s): WO2006/026395

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280088-Superabsorbent polymers in agricultural applications

2005280058-Pharmaceutical formulations of potassium ATP channel openers and uses thereof